( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
28092.01
27657.35
24639.17
22283.61
Total Expenditure
24948.69
24562.9
21985.07
19700.98
PBIDT (Excl OI)
3143.32
3094.45
2654.1
2582.63
Other Income
27.53
67.5
370.64
312.74
Operating Profit
3170.85
3161.95
3024.74
2895.37
Interest
349.49
280.25
279.87
257.12
Exceptional Items
NA
NA
NA
NA
PBDT
2821.36
2881.7
2744.87
2638.25
Depreciation
628.78
598.79
523.49
531.07
Profit Before Tax
2192.58
2282.91
2221.38
2107.18
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1562.43
1630.23
1623.38
1552.99
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1562.43
1630.23
1623.38
1552.99
Minority Interest
NA
NA
NA
NA
Shares of Associates
11.09
8.31
61.66
52.21
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1573.52
1638.54
1685.05
1605.19
Equity Capital
347.25
347.25
347.25
347.25
Calculated EPS
4.53
4.71
4.85
4.62
Calculated EPS (Annualised)
18.12
18.87
19.41
18.49
No of Public Share Holdings
170136038
170138038
170138038
170138038
% of Public Share Holdings
48.99
49
49
49
PBIDTM% (Excl OI)
11.18
11.18
10.77
11.58
PBIDTM%
11.28
11.43
12.27
12.99
PBDTM%
10.04
10.41
11.14
11.83